Related Experiment Videos
Factors in prostate cancer metastasis
1Department of Endocrinology, Acad. Ziekenhuis Vrije Universiteit, Amsterdam, The Netherlands.
Anticancer Research
|September 1, 1990
Summary
The R3327 rat prostate tumor model aids in understanding prostate cancer metastasis to lymph nodes, lungs, and bone. This model allows for in vivo investigation of metastatic processes and evaluation of various treatment strategies.
Area of Science:
- Oncology
- Cancer Metastasis Research
- Animal Models in Cancer
Background:
- Prostate cancer mortality is primarily driven by tumor metastasis.
- Understanding the mechanisms of cancer cell spread is crucial for developing effective treatments.
- The R3327 prostate tumor model in Copenhagen rats provides a valuable platform for studying metastasis.
Purpose of the Study:
- To investigate the metastatic processes of prostate cancer in vivo.
- To evaluate the efficacy of different treatment approaches on metastasis.
- To utilize the R3327 rat prostate tumor model for comprehensive metastasis research.
Main Methods:
- Quantifying lymphatic spread by measuring lymph node tumor burden.
- Assessing lung metastasis through enumeration of pleural lung colonies.
- Inducing bone metastasis via venous occlusion and observing functional deficits.
Main Results:
- Lymphatic metastasis in the R3327-MATLyLu variant is a progressive phenomenon starting early in tumor growth.
- Lung metastasis can be effectively mimicked and quantified.
- Induced vertebral metastasis led to spinal cord compression and hind leg dysfunction, enabling functional studies.
Conclusions:
- The R3327 rat prostate tumor model is suitable for studying various aspects of prostate cancer and its metastasis.
- This model facilitates in vivo investigation of lymphatic, lung, and bone metastasis.
- The model allows for the evaluation of therapeutic interventions against prostate cancer spread.